Clarithromycin and Imuran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clarithromycin (clarithromycin) and Imuran (azathioprine). Common drug interactions include dwarfism among females and drug hypersensitivity among males.

The phase IV clinical study analyzes what interactions people have when they take Clarithromycin and Imuran. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.

What is Clarithromycin?

Clarithromycin has active ingredients of clarithromycin. It is often used in sinusitis. eHealthMe is studying from 45,044 Clarithromycin users. Check the latest studies of Clarithromycin.

What is Imuran?

Imuran has active ingredients of azathioprine. It is often used in crohn's disease. eHealthMe is studying from 34,915 Imuran users. Check the latest studies of Imuran.



On Jul, 09, 2026

55 people who take Clarithromycin and Imuran together, and have interactions are studied.

Clarithromycin and Imuran drug interactions.

What are the common drug interactions of Clarithromycin and Imuran, by gender? *:

female:

  1. Dwarfism (abnormally low stature)
  2. Dyspnoea (difficult or laboured respiration)
  3. Fatigue (feeling of tiredness)
  4. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  5. Muscle spasms (muscle contraction)
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Oedema peripheral (superficial swelling)
  8. Pneumocystis carinii pneumonia (pneumonia occurring in infants or in persons with impaired immune systems)
  9. Psoriasis (immune-mediated disease that affects the skin)
  10. Pyrexia (fever)

male:

  1. Drug hypersensitivity
  2. Otitis media (inflammation of the middle ear)
  3. Ascites (accumulation of fluid in the abdominal cavity)
  4. Blood lactate dehydrogenase increased
  5. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  6. Cough
  7. Cryoglobulins present
  8. Deafness
  9. Erythema (redness of the skin)
  10. Joint swelling

What are the common drug interactions of Clarithromycin and Imuran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Diabetes insipidus (diabetes caused by a deficiency of the pituitary hormone vasopressin, which regulates kidney function)
  2. Dwarfism (abnormally low stature)
  3. C-reactive protein increased
  4. Growth hormone deficiency
  5. Hypokalaemia (low potassium)
  6. Hypophysitis (inflammation of the pituitary gland)
  7. Lymphocytic hypophysitis (inflammation of the pituitary gland)
  8. Pyrexia (fever)

10-19:

  1. Ascites (accumulation of fluid in the abdominal cavity)
  2. Cryoglobulins present
  3. Leukopenia (less number of white blood cells in blood)
  4. Vasculitis (inflammation of a blood vessel or blood vessels)
  5. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  6. Autoimmune hepatitis
  7. Blood bilirubin increased
  8. Cardiomyopathy (weakening of the heart muscle)
  9. Chest tightness
  10. Decreased activity

20-29:

  1. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  2. Chylothorax (collection of lymph fluid around the lung)
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  5. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  6. Hyperglycaemia (high blood sugar)
  7. Lymphatic duct rupture (damage of lymph duct)
  8. Pleural effusion (water on the lungs)
  9. Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus)
  10. Renal impairment (severely reduced kidney function)

30-39:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Hepatic enzyme increased
  3. Hepatic failure (liver failure)
  4. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

40-49:

  1. Dyspnoea (difficult or laboured respiration)
  2. Dyspnoea exertional (breathlessness or shortness of breath)
  3. Enterocolitis viral
  4. Face oedema (swelling of face)
  5. Fall
  6. Fatigue (feeling of tiredness)
  7. Headache (pain in head)
  8. Heart rate irregular
  9. Hypercholesterolaemia (high levels of cholesterol in the blood)
  10. Intraocular pressure increased

50-59:

  1. Drug hypersensitivity
  2. Obliterative bronchiolitis (bronchiolar inflammation)
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Blood cholesterol increased
  6. Blood lactate dehydrogenase increased
  7. Blood pressure increased
  8. Depressed level of consciousness
  9. Gamma-glutamyltransferase increased
  10. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

60+:

  1. Gamma-glutamyltransferase increased
  2. Otitis media (inflammation of the middle ear)
  3. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  4. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  5. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  6. Postmenopausal haemorrhage (post-menopausal bleeding)
  7. Skin cancer
  8. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
  9. Upper respiratory tract infection
  10. Alanine aminotransferase increased

What are the existing conditions these people have? *

  1. Osteoporosis (bones weak and more likely to break): 7 people, 12.73%
  2. Immunodeficiency Common Variable: 7 people, 12.73%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 9.09%
  4. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 5.45%
  5. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 3 people, 5.45%
  6. Seasonal Allergy (allergic condition due to certain season): 3 people, 5.45%
  7. Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 5.45%
  8. Pachymeningitis (inflammation of the dura mater or outer membrane of the brain): 3 people, 5.45%
  9. Mycobacterium Chelonae Infection (bacterial infection): 3 people, 5.45%
  10. Interstitial Lung Disease: 3 people, 5.45%

* Approximation only. Some reports may have incomplete information.

Do you take Clarithromycin and Imuran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clarithromycin and Imuran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clarithromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Imuran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clarithromycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imuran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on clarithromycin and azathioprine (the active ingredients of Clarithromycin and Imuran, respectively), and Clarithromycin and Imuran (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: